Fahar Merchant | President & CEO |
Liz Williams | CFO |
Martin Bexon | CMO |
Rosemina Merchant | CDO |
Dan Ferry | LifeSci Advisors, IR |
Matt Biegler | Oppenheimer & Co. Inc. |
David Martin | Bloom Burton |
Swayampakula Ramakanth | H.C. Wainwright & Co. |
Shubhendu Roy | Brookline Capital Markets |
David Bautz | Zacks Small-Cap Research. |
Greetings, and welcome to Medicenna Therapeutics Third Quarter Fiscal 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator instructions].
As a reminder, this conference is being recorded.